Guo‐Bo Li
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Chemical Synthesis and Analysis 9
-
- Synthesis and biological activity 8
- Co-authors
- Lingling Yang (30 shared papers)Shengyong Yang (23 shared papers)Linli Li (7 shared papers)Yu‐Hang Yan (22 shared papers)Qing-Qing Dai (10 shared papers)Yong Wu (16 shared papers)Junlin Yu (11 shared papers)Wenjing Wang (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (15 papers)European Journal of Medicinal Chemistry (12 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)RSC Advances (4 papers)Journal of Chemical Information and Modeling (3 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Guo‐Bo Li
111 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 139
- Molecular Medicine 330
- Geriatrics and Gerontology 218
- Physiology 107
- Organic Chemistry 639
- Biological Psychiatry 54
Countries citing papers authored by Guo‐Bo Li
This map shows the geographic impact of Guo‐Bo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Bo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Bo Li more than expected).
Fields of papers citing papers by Guo‐Bo Li
This network shows the impact of papers produced by Guo‐Bo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Bo Li. The network helps show where Guo‐Bo Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guo‐Bo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 141 | |
| 2 | 2018 | 96 | |
| 3 | 2020 | 93 | |
| 4 | 2021 | 82 | |
| 5 | 2015 | 66 | |
| 6 | 2013 | 64 | |
| 7 | 2017 | 61 | |
| 8 | 2016 | 61 | |
| 9 | 2016 | 60 | |
| 10 | 2018 | 54 | |
| 11 | 2021 | 53 | |
| 12 | 2018 | 48 | |
| 13 | 2018 | 47 | |
| 14 | 2019 | 47 | |
| 15 | 2020 | 43 | |
| 16 | 2020 | 43 | |
| 17 | 2015 | 42 | |
| 18 | 2021 | 41 | |
| 19 | 2017 | 41 | |
| 20 | 2023 | 39 |
About Guo‐Bo Li
Guo‐Bo Li is a scholar working on Molecular Biology, Organic Chemistry, Epidemiology, Molecular Medicine and Oncology, having authored 116 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (17 papers), Computational Drug Discovery Methods (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers), Sirtuins and Resveratrol in Medicine (10 papers), Chemical Synthesis and Analysis (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Synthesis and biological activity (8 papers) and Tryptophan and brain disorders (6 papers). The work is most often cited by research in Molecular Medicine (330 citations), Geriatrics and Gerontology (218 citations), Physiology (107 citations), Organic Chemistry (639 citations) and Biological Psychiatry (54 citations). Guo‐Bo Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Lingling Yang, Shengyong Yang, Linli Li, Yu‐Hang Yan, Qing-Qing Dai, Yong Wu, Junlin Yu, Wenjing Wang, Zhujun Yu and Gen Li. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, RSC Advances and Journal of Chemical Information and Modeling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.